Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block in Hip Arthroscopy
NCT05118620Phase 4Withdrawn
- Sponsor
- University of California, San Diego
- Start
- Dec 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by University of California, San Diego. Primary endpoints: Numeric Rating Scale Pain Score in Recovery Room and Total Opioid Consumption in Recovery Room. Planned start Dec 2021; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05118620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05118620.